What Mtech Access does

Mtech Access is a UK-headquartered health economics and outcomes research (HEOR) and global market access consultancy serving pharmaceutical, biotechnology, medical device, and diagnostics companies. Founded in 2015 and headquartered in Bicester, Oxfordshire, the firm operates from six UK locations (Bicester, London, Manchester, York, Newcastle, Cambridge) and delivers projects across Europe, North America, and Asia-Pacific. Its service portfolio spans the full market access lifecycle — from early opportunity assessment, pricing and reimbursement strategy, target product profile testing, and global market access strategy, through to evidence synthesis (systematic literature reviews, network meta-analyses), health economic modelling (cost-effectiveness, budget impact, Markov, discrete event simulation), HTA submissions (NICE, SMC, NCPE, AWMSG, JCA, AMCP, CADTH, PBAC), and local market launch support including payer engagement and field team training. The firm also delivers Education & Training workshops and HTA mock appraisal meetings.

The company's technology stack centres on proprietary in-house digital platforms rather than third-party software. Core products include Connected Insights (a real-world data visualisation and health-economy performance indicator dashboard), the Global Value Platform (an interactive digital repository linking value dossiers, economic models, and published literature for global-to-local affiliate distribution), configurable Budget Impact Models, and dynamic eDetail Solutions and Interactive Visual Aids deployable on iPad, Windows, and web. Mtech Access is a full-service Veeva content partner, integrating its digital tools directly with Veeva CRM, Veeva PromoMats, Veeva Engage for Meetings, and Approved Email. The firm maintains a network of 80-100+ contracted NHS Associates occupying operational, strategic, and clinical roles within the NHS, providing real-world payer insight that strengthens model and strategy design. It reports 270+ health economic projects across 65+ clients, 395+ evidence synthesis projects across 50+ clients, and 170+ HTA submission sets, with a stated 100% success rate on UK oncology and rare disease HTA submissions as of September 2024.

The business model is fee-for-service professional consulting combined with project-based digital tool development and licensing. Revenue is generated on a quote-based, project-by-project basis through direct enterprise engagement, RFPs, and procurement platforms including Ariba Network, Scientist.com, and Coupa; pricing is not publicly disclosed. Distribution is direct enterprise field sales supported by content marketing (LinkedIn, Twitter/X, YouTube, the NHS Whispers and Global Whispers podcasts, webinars, blog/white papers), industry events (ISPOR, World EPA Congress), and case-study/testimonial collateral. In June 2024, Mtech Access joined the Petauri pharmaceutical services platform and subsequently merged with Delta Hat to form the Petauri Evidence business unit, while continuing to operate under its existing legal entity (Mtech Access Limited, UK Company No. 09875447). The combined firm targets pharmaceutical, biotech, medtech, and diagnostics clients globally, with primary revenue derived from Top 20 pharma accounts and similar-tier medtech enterprises.

Name

Mtech Access

Legal name

Mtech Access Limited

Website

https://mtechaccess.co.uk

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Mtech Access is a UK-headquartered HEOR and global market access consultancy serving pharmaceutical, biotechnology, medical device, and diagnostics clients with evidence synthesis, health economic modelling, HTA submissions, and proprietary digital value communication tools, now operating as Petauri Evidence within the Petauri platform.

Ownership category

akta.pro rank

Headquarters

HQ city

Oxford

HQ country

United Kingdom

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Professional Consulting Services: Mtech Access generates revenue through fee-for-service consulting engagements across market access strategy, HEOR, health economics modelling, systematic literature reviews, HTA submissions, and value communication. Projects are commissioned by pharmaceutical, biotech, medical device and diagnostics companies on a project-by-project basis. Pricing is quote-based and not publicly disclosed.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels10 records

Core offering

Mtech Access is a UK-headquartered health economics and outcomes research (HEOR) and market access consultancy serving pharmaceutical, biotechnology, medical device, and diagnostics companies globally. The firm delivers end-to-end services spanning market access strategy, evidence synthesis (systematic literature reviews and network meta-analyses), health economic modelling, HTA submissions (NICE, SMC, NCPE, AWMSG, JCA, AMCP, CADTH, PBAC), and value communication, complemented by proprietary digital platforms (Connected Insights, Global Value Platform, Budget Impact Models, eDetail solutions) integrated with Veeva CRM.

Product overview

Mtech Access (now operating as Petauri Evidence) offers a suite of market access and HEOR consulting services combined with proprietary digital tools. The portfolio includes the Global Value Platform for housing and sharing value dossiers, Budget Impact Models and eDetail Solutions as interactive digital communication tools, Connected Insights for real-world data visualisation, and the Digital Video Library for showcasing capabilities. These digital platforms are complemented by consulting services including Systematic Literature Reviews, HEOR, Health Economics modelling, HTA Support, and Education & Training. The offering integrates with Veeva CRM as a full-service Veeva content partner.

Differentiator

Problem solved

Functional benefit

Brands

• Petauri Evidence: An innovative new business unit within the Petauri platform that unites Mtech Access and Delta Hat, dedicated to helping pharmaceutical, biotechnology, and medical device companies generate, apply, and communicate evidence to inform healthcare decision-making.

Products and services

• Global Value Platform Interactive digital platform that enables global market access teams to house and share a suite of interlinked global market access materials with local affiliates, including value presentations, economic models, value dossiers, and published literature, with local market tailoring capabilities.
• Budget Impact Models Interactive budget impact models developed for iPad, Windows, or as web-based tools that enable account managers to adapt key parameters to reflect payer-specific circumstances, with CRM integration (including Veeva) and post-call report generation.
• eDetail Solutions and Interactive Visual Aids Fully dynamic, data-driven interactive apps and websites for field teams to use with healthcare decision-makers, with compliant yet flexible content allowing account managers to adjust key data or select from pre-approved options during customer engagements, cross-platform compatible for iPad, Windows, and online.
• Connected Insights A real-world data visualisation platform enabling Pharma and Medtech clients to create, manage and deploy health economy performance indicator dashboards that present disease prevalence and management metrics, supporting field teams in building evidence-based cases for change with healthcare decision-makers.
• Systematic Literature Review and Network Meta-Analysis Services Evidence synthesis services including systematic literature reviews, rapid reviews, scoping reviews, meta-analyses, and network meta-analyses to support HTA submissions and market access evidence generation, with 395+ projects delivered across 50+ clients and 60+ meta-analysis feasibility or subsequent meta-analysis projects.
• HEOR Services Health Economics and Outcomes Research services combining health economics and evidence synthesis to generate clinical and economic evidence supporting internal and external healthcare decision-making.
• Health Economics Services Cost-effectiveness and budget impact modelling services including decision trees, Markov models, partitioned survival models, and discrete event simulations for HTA submissions and market access support, with 270+ health economic projects delivered to 65+ clients.
• HTA Support Services Full Health Technology Assessment submission support including evidence generation, dossier writing, NICE, SMC, NCPE, AWMSG, JCA, AMCP, CADTH, and PBAC submissions, expert elicitation, advisory boards, and post-submission strategic advice, with 170+ HTA submissions and 100% success rate on UK oncology and rare disease submissions as of September 2024.
• Global Market Access and Pricing Consulting End-to-end market access consulting from strategy to implementation covering pricing, reimbursement strategy, evidence generation, value communication, and global value platform deployment for pharmaceutical and medical device companies across UK, EU, North America, and Asia-Pacific markets.
• Education and Training Services Strategic workshops, insights sessions, and technical training for market access and HEOR teams including payer negotiation, mock HTA meetings, health economics training, and field team training.

Quantifiable outcome

• 170+ HTA submissions completed with high success rates, including 100% success on UK oncology and rare disease submissions
• +2 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Partnerships

One partnership is on record.

• PetauricoreStrategic or Co-development Partner · 1 June 2024Mtech Access joined Petauri in June 2024, a purpose-built pharmaceutical services platform. Mtech Access and Delta Hat combined under the Petauri Evidence business unit, dedicated to helping pharmaceutical, biotechnology, and medical device companies generate, apply, and communicate evidence to inform healthcare decision-making.

Scale indicators12 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Costello Medical: UK-headquartered scientific communications and HEOR consultancy offering evidence synthesis, health economics, HTA submissions and market access services to pharma and medtech - the closest direct comparable to Mtech Access in size, geography and service mix.
• BresMed: Specialist HEOR and market access consultancy delivering health economic modelling, evidence synthesis and HTA support to pharma and medtech clients across the UK and globally; a direct competitor to Mtech Access's core HTA and health economics service lines.
• York Health Economics Consortium: University of York-affiliated HEOR group providing systematic reviews, health economic modelling and HTA submission support to pharma and medtech; comparable to Mtech Access's evidence synthesis, health economics and NICE/SMC/NCPE submission offerings.
• Source Health Economics: Independent UK-based HEOR consultancy delivering systematic reviews, economic models and HTA submissions for pharma clients; competes directly with Mtech Access for similar NICE/SMC/NCPE engagement work.
• Putnam Associates: Global strategy and market access consulting firm serving pharmaceutical and medtech clients with commercial, pricing and HEOR support; comparable to Mtech Access for its enterprise pharma-facing market access capabilities.

Broad incumbents

• IQVIA: Global CRO and life-sciences services leader with extensive HEOR, real-world evidence, HTA and market access capabilities embedded in a much broader clinical and commercial portfolio; a broad incumbent that competes with Mtech Access across most service lines.
• ICON plc: Large global CRO offering health economics, outcomes research and market access services alongside clinical development; overlaps with Mtech Access's HEOR and evidence generation offerings as part of a wider pharmaceutical services portfolio.
• Parexel: Global clinical research and consulting services provider with market access, HEOR and HTA capabilities across pharma and medtech; a broad incumbent whose market access practice competes with Mtech Access for enterprise engagements.
• Syneos Health: Clinical and commercial solutions provider combining CRO services with market access, HEOR and real-world evidence offerings for pharma; comparable to Mtech Access for the market access and HEOR components of its services.
• Xcenda: Market access, HEOR and consulting arm of Cencora focused on pharma and payer clients; overlaps with Mtech Access on health economics, HTA support and value communication work, but operating at much larger scale as part of a global distribution platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Mtech_Access
• YouTubeyoutube.com/channel/UCxSyFuVJZ_qYgXHfkB4pL5g
• LinkedInlinkedin.com/company/mtech-access

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mtech Access